Consensus Modeling Strategies for Predicting Transthyretin Binding Affinity from Tox24 Challenge Data
Transthyretin (TTR) is a key transporter of the thyroid hormone thyroxine, and chemicals that bind to TTR, displacing the hormone, can disrupt the endocrine system, even at low concentrations. This study evaluates computational modeling strategies developed during the Tox24 Challenge, using a data set of 1512 compounds tested for TTR binding affinity. Individual models from nine top-performing teams were analyzed for performance and uncertainty using regression metrics and applicability domains (AD). Consensus models were developed by averaging predictions across these models, with and without consideration of their ADs. While applying AD constraints in individual models generally improved external prediction accuracy (at the expense of reduced chemical space coverage), it had limited additional benefit for consensus models. Results showed that consensus models outperformed individual models, achieving a root-mean-square error (RMSE) of 19.8% on the test set, compared to an average RMSE of 20.9% for the nine individual models. Outliers consistently identified in several of these models indicate potential experimental artifacts and/or activity cliffs, requiring further investigation. Substructure importance analysis revealed that models prioritized different chemical features, and consensus averaging harmonized these divergent perspectives. These findings highlight the value of consensus modeling in improving predictive performance and addressing model limitations. Future work should focus on expanding chemical space coverage and refining experimental data sets to support public health protection.
Authors
- Zaven Navoyan
- Lusine Khondkaryan (ORCID: https://orcid.org/0000-0003-0578-0758)
- Koki Shishido (ORCID: https://orcid.org/0000-0002-3100-6216)
- Yoshihiro Iwashita
- Narek Abelyan (ORCID: https://orcid.org/0000-0002-2937-8985)
- Nelly Babayan (ORCID: https://orcid.org/0000-0001-9205-7693)
- Ani Tevosyan
- Yoshihiro Uesawa (ORCID: https://orcid.org/0000-0002-5773-991X)
- Haobo Wang (ORCID: https://orcid.org/0000-0003-0634-1175)
- Bono Lučić (ORCID: https://orcid.org/0000-0001-7232-2007)
- Vladimir Chupakhin (ORCID: https://orcid.org/0000-0003-1097-8603)
- Alexey Zakharov (ORCID: https://orcid.org/0000-0003-2466-1711)
- Mizuho Asada
- L. Masfarre Pinto (ORCID: https://orcid.org/0009-0000-5147-2145)
- Sankalp Jain (ORCID: https://orcid.org/0000-0002-9370-9611)
- Wenjia Liu (ORCID: https://orcid.org/0000-0002-0627-2731)
- K Kimura (ORCID: https://orcid.org/0009-0000-1632-2897)
- Vahe Atoyan
- Taichi Nakamura
- Alexis Dougha (ORCID: https://orcid.org/0009-0004-2384-756X)
- Hrach Yeghiazaryan
- Thalita Cirino
- Tomoya Komasaka
- Mateusz Iwan
- Antonija Kraljević
Institutions
- Centre National de la Recherche Scientifique (FR)
- University of Mostar (BA)
- Inserm (FR)
- Biocon (Switzerland) (CH)
- Mario Negri Institute for Pharmacological Research (IT)
- Université Paris Cité (FR)
- Meiji Pharmaceutical University (JP)
- Dalian University of Technology (CN)
- Beijing Film Academy (CN)
- Endometriosis UK (GB)
- Ruđer Bošković Institute (HR)
- National Center for Advancing Translational Sciences (US)
- University of Turin (IT)
- Simulations Plus (United States) (US)
Publication Details
- Journal
- Chemical Research in Toxicology
- Published
- 2025-05-15
- DOI
- https://doi.org/10.1021/acs.chemrestox.5c00018
- Citations
- 6
- Primary Topic
- Computational Drug Discovery Methods
- Type
- article
- Field-Weighted Citation Impact
- 9.03
Funders
- State Committee of Science
- National Center for Advancing Translational Sciences
- HORIZON EUROPE Marie Sklodowska-Curie Actions